Boston Scientific : Performance Report (BostonScientific2024PerformanceReport)
BSX
Published on 06/27/2025 at 03:21
2024 PERFORMANCE REPORT
CARE
INTRODUCTION INNOVATIVE
EMPOWERED PEOPLE
HEALTHIER PLANET
PERFORMANCE WITH INTEGRITY
APPENDIX
Mike Olson has always been full of energy. Whether taking on home improvement projects or tending to the yard, Mike thrives on keeping active. According to his wife Laura, he's happiest when he has a project in the works. But over time, something in Mike started to change.
"The decline was gradual," he recalls. "Yard work was getting harder, and things that never bothered me started to feel exhausting, but I thought I was just getting older."
Then one day his daughter, Katy Jo, gave him a hug and noticed something was off. She asked him why his heart was beating so fast, but Mike had no idea what she was talking about. He checked his blood pressure, but couldn't even get a reading because his heart was in such an erratic rhythm. A trip to the doctor revealed something far more serious: Mike was in heart failure due to atrial fibrillation (AF).
"It hit me like a ton of bricks," he admits. "Heart failure? Me? That was when I knew I needed to take this seriously." Mike's wife, Laura, a meeting and events specialist in our Electrophysiology division, knew the risks all too well.
Mike's physician recommended treatment with the FARAPULSE™ Pulsed Field Ablation (PFA) System, an innovative therapy for treating AF, and one that uses precise electrical fields to target and treat heart tissue while minimizing damage to surrounding structures, such as the esophagus. With his family's support, Mike underwent the procedure. The experience was straightforward and largely pain-free, and Mike felt better almost immediately. "I remember thinking, 'Wow, my heart is functioning better!'"
Mike is back doing everything he loves: tackling home projects, staying active outdoors and spending quality time with family. "It's a huge blessing for me to be here. Every day is a joy," he says.
We wholeheartedly agree. At Boston Scientific we are advancing science for life to give more patients like Mike more moments with the people they love.
"It's a huge blessing for me to be here.
Every day is a joy."
Mike Olson
Treated with the FARAPULSE™ PFA System
2024 Performance Report | 2
CARE
INTRODUCTION INNOVATIVE
EMPOWERED PEOPLE
HEALTHIER PLANET
PERFORMANCE WITH INTEGRITY
APPENDIX
Table of contents
Introduction
A message from our Chairman and Chief Executive Officer
What guides us: Our purpose, mission and core values
Boston Scientific: 2024 at a glance
Acting on our corporate responsibility
10 Our progress: 2024 corporate responsibility highlights
11 Innovative care
13 Innovating to improve patient lives
18 Committed to quality, health and safety
19 Advancing access to healthcare
22 Empowered people
24 Developing our global workforce
29 Fostering an inclusive workplace
31 Caring for our employees
32 Working with our communities
35 Healthier planet
37 Confronting climate change
42 Embedding product stewardship
44 Addressing water, waste and biodiversity
45 Performance
with integrity
47 Governance and compliance
Risk management
Cybersecurity
A responsible supply chain
53 Appendix
54 Materiality
55 Stakeholder engagement
56 Metrics summary
64 Global Reporting Initiative index
70 Sustainability Accounting Standards Board index
72 Task Force on Climate-related Financial Disclosures index
United Nations Sustainable Development Goals
Key manufacturing and distribution sites
Cautionary Statement Regarding Forward-Looking Statements
Footnotes
This report has been prepared with reference to the Global Reporting Initiative (GRI) Standards as well as alignment with the Sustainability Accounting Standards Board (SASB) standards for the Medical Equipment & Supplies industry and the Task Force
on Climate-related Financial Disclosures (TCFD) recommendations. Unless otherwise indicated, data in this 2024 Performance Report and appendix are as of, or for the year ended, December 31, 2024, as applicable. Please refer to the appendix for detailed metrics and key definitions used within this report.
Reporting on other matters specific to financial performance of the company and its subsidiaries can be found in our 2024 Annual Report. See page 78 for footnotes.
2024 Performance Report | 3
CARE
INTRODUCTION INNOVATIVE
EMPOWERED PEOPLE
HEALTHIER PLANET
PERFORMANCE WITH INTEGRITY
APPENDIX
Advancing science for more innovative care, empowered people and a healthier planet.
In this section:
5 A message from our Chairman and Chief Executive Officer
6 What guides us: Our purpose, mission and core values
7 Boston Scientific: 2024 at a glance
8 Acting on our corporate responsibility
10 Our progress: 2024 corporate responsibility highlights
2024 Performance Report | 4
CARE
INTRODUCTION INNOVATIVE
EMPOWERED PEOPLE
HEALTHIER PLANET
PERFORMANCE WITH INTEGRITY
APPENDIX
"Our work at Boston Scientific is about more than developing innovative technologies - it's about advancing science for life.
We are making a real difference for patients, customers and communities around the world, and I'm grateful for the dedication of our global team."
This is an incredibly exciting time to be at Boston Scientific, one marked by significant growth and ambitious goals for future innovations. Our high
performance across the company is fueled by our purpose of advancing science for life. We are as dedicated as ever to tackling healthcare's biggest challenges so patients can experience more of what truly matters - more time to connect with loved ones, more celebrating, more living - a conviction our 53,000 global employees bring to their work every day.
Our 2024 results demonstrate the power of that purpose. Our teams expanded our manufacturing, supply chain and digital capacities to meet growing demand, launched approximately 100 products and fueled our pipeline by investing
$1.6 billion into research and development.1To better serve patients, we worked to improve access to the life-changing devices and procedures people need, generated new evidence through clinical trials and invested $89 million to fund medical research, fellowships, education and charitable organizations. Because human health is inextricably linked to the health of our environment, we also progressed toward our science-based emission reduction targets, including
achieving our goal of 100% renewable electricity.2,3But of all our accomplishments, the one that makes me proudest is that we helped improve the lives of more than 44 million patients around the world.
No matter how much progress we make, there's always much more to do. I know that our values-driven global teams remain committed to the work ahead and that together we'll continue to transform lives through innovative medical solutions.
Mike Mahoney
Chairman and Chief Executive Officer, Boston Scientific
2024 Performance Report | 5
Disclaimer
Boston Scientific Corporation published this content on June 26, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on June 27, 2025 at 07:20 UTC.